Samsrita Labs
24.31
+2.20(+9.95%)
Market Cap₹55.30 Cr
PE Ratio-170.08
Company Performance:
1D+9.95%
1M+25.50%
6M+13.60%
1Y+28.76%
5Y-52.00%
View Company Insightsright
More news about Samsrita Labs
23Jul 25
Samsrita Labs Sees 7.10% Stake Acquisition Through Preferential Allotment
Perla Naga Pattabhi Ravikanth has acquired a 7.10% stake (16,16,001 equity shares) in Samsrita Labs Limited through a preferential allotment on a swap basis. The allotment occurred on July 18, 2025, changing Ravikanth's shareholding from 0 to 16,16,001 shares. This acquisition has triggered disclosure requirements under SEBI regulations. Samsrita Labs is listed on the Metropolitan Stock Exchange of India Limited, and the acquirer is not part of the promoter group.
21Jul 25
Samsrita Labs Limited Allots 33.91 Lakh Equity Shares in Preferential Issue
Samsrita Labs Limited's board approved a preferential allotment of 33.91 lakh equity shares to non-promoters at Rs. 10 per share, raising Rs. 3.39 crore. Four individuals, led by Mallikarjun Rao Basaboini and Basaboini Malathi, acquired a combined 6.56% stake. The company's share capital increased from 1.48 crore to 2.28 crore equity shares, representing a 54.3% expansion. The allotment complies with SEBI regulations and significantly alters the company's ownership structure.
Samsrita Labs
24.31
+2.20
(+9.95%)
1 Year Returns:+28.76%
Industry Peers
Dr. Lal Path Labs
3,208.10
(+0.80%)
Vijaya Diagnostic Centre
1,004.60
(-1.99%)
Metropolis Healthcare
1,942.30
(+0.69%)
Thyrocare Technologies
1,564.00
(-1.75%)
Krsnaa Diagnostics
821.45
(+0.94%)
Suraksha Diagnostic
306.05
(+1.19%)
3B BlackBio DX
1,321.15
(-1.39%)
Sastasundar Ventures
319.25
(+3.60%)
Choksi Laboratories
139.35
(-2.48%)